Neuroleptic malignant syndrome in parkinsonian patients: Risk factors

European Neurology

Volumn 38, Issue , 1997, Pages 56-59

  Kuno, Sadako ^a   Mizuta, Eiji ^a   Yamasaki, Shunzo ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Antiparkinsonian drugs; Neuroleptic malignant syndrome; Parkinson s disease; Risk factors

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

CONFERENCE PAPER; DEHYDRATION; DRUG WITHDRAWAL; HUMAN; MENSTRUAL CYCLE; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SEASONAL VARIATION;

AGED; ANTIPARKINSON AGENTS; DOPAMINE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLEPTIC MALIGNANT SYNDROME; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; RISK FACTORS; SEASONS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0030692836     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113484     Document Type: Article

References (12)

1. Kurlan R, Hamill R, Shoulson I: Neuroleptic malignant syndrome, Clin Ncuropharmacol 1984;7:109-120.
2. Snyder SH, Banerjcc SP, Yamamura HI, Greenberg D: Drugs, neurotransmitters and schizophrenia, Science 1974;184:1243-1253.
3. Henderson VW, Wooten GF: Neuroleptic malignant syndrome: A pathogenetic role for dopamine receptor blockade? Neurology 1981:31: 132-137.
4. Torn M, Matsuda O, Makiguchi K, Sugano K: Neuroleptic malignant syndrome-like state following a withdrawal of antiparkinsonian drugs, J Nerv Ment Dis 1981:169:324-327.
5. Sechi GP, Tanda F, Mutani R: Fetal hyperpyrexia after withdrawal of levodopa, Neurology 1984;34:249-251.
6. Friedman JH, Feinberg SS, Feidman RG: A neuroleptic malignant-like syndrome due to levodopa therapy withdrawal, JAMA 1985; 254:2792-2795.
7. Kuno S, Komure O, Mizuta H, Yamazaki S, Nishitani H: Neuroleptic malignant syndrome associated with withdrawal of antiparkinsonian drugs: in Nagatsu T, Fischer A, Yoshida M (eds): Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, New York, Plenum Press, 1990. vol 2. pp 245-248.
8. Mizuta E, Yamasaki S, Nakatakc M, Kuno S: Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period, Neurology 1993;43:1048-1049.
9. Quinn NP, Marsden CD: Menstrual-related fluctuations in Parkinson's disease, Mov Disord 1986;1:85-87.
10. Pfeiffer RF, Sucha EL: ‘On-ofT-induced lethal hyperthermia, Mov Disord 1989:4:338-341.
11. Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL: The ‘on-off phenomenon in Parkinson's disease: Relation to levodopa absorption and transport, N Engl J Med 1984;310:483-488.
12. Caroff SN, Mann SC: Neuroleptic malignant syndrome, Psychopharmacol Bull 1988:24:25-29.